Genomenon Raises $2.5M, Plans to Increase Work with Pharma Customers

Genomenon is the maker of Mastermind , an artificial intelligence-powered search engine that combs scientific publications for information on gene variants to help guide doctors to faster and more accurate diagnoses for patients with cancer or rare diseases. Klein says that Genomenon’s client base started as mostly cancer and genetics labs but now has expanded to pharmaceutical companies seeking to “leverage data in drug discovery. An infant was having a dozen seizures per day and doctors couldn’t land on a diagnosis, so they sequenced the baby’s genome and ran the results through Mastermind. Denise Graves, the university relations director at the MEDC, says that to date, MTRAC has reviewed 456 proposals, funding 183 of them and licensing 24. Later this month, Graves says the state is expected to approve a new MTRAC program—which are divided by sector and administered by various Michigan universities—for advanced computing.